
© 2024 Edison Investment Research
Zeit | Aktuelle Nachrichten | |
---|---|---|
Mi | Artificial Intelligence Technology Solutions, Inc.: Immix and AITX's Robotic Assistance Devices (RAD) Announce Plans to Develop Strategic Integration to Advance Real-Time Incident Management with AI-Driven Automation | |
27.03. | Immix Biopharma (NASDAQ:IMMX) Issues Quarterly Earnings Results, Beats Estimates By $0.09 EPS | |
13.02. | Immix Biopharma - NXC-201 receives FDA RMAT designation | |
10.02. | Immix Biopharma, Inc.: Immix Biopharma Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for NXC-201, sterically-optimized CAR-T for relapsed/refractory AL Amyloidosis | |
15.01. | Immix Biopharma - Shifting the ALA treatment paradigm with CAR-T |